Hope through Science
Thirty-plus years of medical research have put Dr. Dale Bredesen, the Chief Science Officer (CSO) of Apollo Health, at the forefront of research into Alzheimer’s disease prevention and memory-loss reversal. His research teams have made discoveries that changed our understanding of the fundamental nature of Alzheimer’s disease and led to revolutionary treatments.
At Apollo Health, we turned Dr. Bredesen’s protocol into action and put the health of your brain back in your hands with the only Bredesen-approved Protocol for preventing, treating, and reversing Alzheimer’s disease and cognitive decline.
First to Publish Reversal of Cognitive Decline
Dr. Dale Bredesen, CSO for Apollo Health, was the first neurodegenerative disease researcher to publish peer-reviewed groundbreaking studies on reversing cognitive decline in Alzheimer’s disease. Everyone knows a cancer survivor, but no one knows an Alzheimer’s survivor, until now.
The following studies shattered preconceived notions and beliefs that Alzheimer’s is unsurvivable, fostering hope for those facing cognitive decline or caring for someone who is.
- Reversal of cognitive decline: a novel therapeutic program (Aging, 2014)
- Reversal of cognitive decline in Alzheimer’s disease (Aging, 2016)
- Reversal of Cognitive Decline: 100 Patients – (Journal of Alzheimer’s Disease & Parkinsonism, 2018)
ReCODE reports are the culmination of Dr. Dale Bredesen’s 30+ years of innovative research in the field of cognitive decline.
The first software product that identifies individualized subtypes of Alzheimer’s disease and cognitive decline.
ReCODE provides an individual roadmap to guide participants and practitioners through the reversal and prevention of Alzheimer’s.
Apollo Health is building the first-ever community around the prevention and reversal of cognitive decline. Our vision is to build communities that support our participants throughout their journeys to manage brain health. Our community members have access to the resources and guides they need to be successful. Apollo Health’s Community encompasses a professional care team of support staff that works with our participants on the One-time ReCODE Report, the ReVERSE Program, and the Bredesen Protocol.
A one-time ReCODE Report is best for individuals without symptoms of cognitive decline or people who are interested in checking their risk factors to developing Alzheimer’s.
- Blood Labs
- ReCODE Report
- Locate a Practitioner
Ongoing Community Support Network
The ReVERSE Program, a monthly subscription plan, is designed for individuals who require more resources to combat cognitive decline. With our qualified Bredesen practitioners, we can provide better and more precise outcomes of care.
- Unlimited ReCODE Reports
- Custom Curated Content
- Brain HQ Exercise Games
- Online Support Forums
- Nutrition Plan and Guidelines
- Access to Coaches and Nutritionists
- Locator Tool to Build Your Care Team
- Much More
Dale Bredesen, MD
An internationally-recognized expert in the mechanisms of neurodegenerative diseases, Dr. Dale Bredesen’s career has been guided by a simple idea: that Alzheimer’s as we know it is not just preventable, but reversible. Thanks to a dedicated pursuit of finding the science that makes this a reality, his idea has placed Dr. Bredesen at the vanguard of neurological research and led to the discoveries that today underlie the ReCode Report.
Dr. Bredesen is a prodigious innovator in medicine, with over thirty patents to his name. Notably, he put much of his findings and research into the 2017 New York Times bestseller The End of Alzheimer’s.
The End of Alzheimer’s is a monumental work. Dr. Bredesen completely recontextualizes this devastating condition away from a mysterious and unsolvable process to one that is both preventable and, yes, reversible.